| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8789920 | Urologic Oncology: Seminars and Original Investigations | 2018 | 5 Pages |
Abstract
In highly comorbid patients, the observation of large renal masses has low likelihood for metastatic progression relative to the risk of nonkidney cancer related death. This data supports the use of surveillance as an acceptable strategy for highly selected patients with competing risks from other serious illnesses.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Karim M.D., Amy M.A., Nick M.D., Daniel M.A., Abraham Ari M.D., Paul M.D., Jonathan M.D.,